The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) Community Study
NCT ID: NCT02092727
Last Updated: 2018-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
134 participants
INTERVENTIONAL
2014-02-28
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Disparities in Access to Kidney Transplantation (RaDIANT) Regional Study
NCT02389387
RaDIANT Health Systems Intervention
NCT07033117
Reducing Disparities in Living Donor Transplant Among African Americans
NCT03819686
Disparities in National Kidney Allocation Policy
NCT02879812
Network Interventions to Reduce Disparities in Living Kidney Donation
NCT05255757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Standard of care arm will receive no specific interventions, but will have access to standard educational materials and quality improvement through End Stage Renal Disease Network 6.
No interventions assigned to this group
Behavioral Intervention
A variety of dialysis facility-level, behavioral interventions will be examined.
Behavioral Interventions for Dialysis Facilities
1. Educational seminars and monthly educational webinars
2. Peer-to-peer mentoring program
3. Bulletin boards about transplantation
4. Facility-specific feedback reports detailing transplant referral data for their center compared to state average
5. Formulate a facility-specific improvement plan to increase transplant referrals.
6. Requirement to form a Patient and Family Advisory Group to increase outreach about transplant education within the facility.
7. Monthly monitoring and reporting of patient referrals to ESRD Network
8. Conduct a patient and family education session about transplantation
9. Host a movie day to show Living ACTS (About Choices in Transplantation \& Sharing) video
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Interventions for Dialysis Facilities
1. Educational seminars and monthly educational webinars
2. Peer-to-peer mentoring program
3. Bulletin boards about transplantation
4. Facility-specific feedback reports detailing transplant referral data for their center compared to state average
5. Formulate a facility-specific improvement plan to increase transplant referrals.
6. Requirement to form a Patient and Family Advisory Group to increase outreach about transplant education within the facility.
7. Monthly monitoring and reporting of patient referrals to ESRD Network
8. Conduct a patient and family education session about transplantation
9. Host a movie day to show Living ACTS (About Choices in Transplantation \& Sharing) video
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The presence of a racial disparity was based on the crude referral risk difference and the standardized referral risk difference.
* The remaining facilities had a calculated 6-month crude referral risk mean of 0.06 and all facilities with a crude referral risk less than the mean were selected for inclusion.
* The final pool of 134 facilities were randomized to either the intervention or control group using a one to one ratio.
Exclusion:
* Facilities with a 6-month population (from June-December 2012) of less than 13 End Stage Renal Disease patients \<70 years of age within a facility were excluded.
18 Years
69 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rachel Patzer, PhD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rachel E Patzer, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dialysis Facilities throughout the State of Georgia, ESRD Network 6
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hamoda RE, Gander JC, McPherson LJ, Arriola KJ, Cobb L, Pastan SO, Plantinga L, Browne T, Hartmann E, Mulloy L, Zayas C, Krisher J, Patzer RE. Process evaluation of the RaDIANT community study: a dialysis facility-level intervention to increase referral for kidney transplantation. BMC Nephrol. 2018 Jan 15;19(1):13. doi: 10.1186/s12882-017-0807-z.
Patzer RE, Gander J, Sauls L, Amamoo MA, Krisher J, Mulloy LL, Gibney E, Browne T, Plantinga L, Pastan SO; Southeastern Kidney Transplant Coalition. The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation. BMC Nephrol. 2014 Oct 28;15:171. doi: 10.1186/1471-2369-15-171.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00056381
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.